In the SURMOUNT-1 trial, 24-26% of participants experienced nausea at some point during the study, most commonly during dose escalation phases
BPC-157 has a favorable safety profile in research with minimal reported adverse effects
Are you constantly feeling tired
Researchers believe this peptide plays an important role in the brain-gut axis and enables this communication between our central nervous and endocrine systems
A pharmacy can compound with a bulk substance only if that substance has a USP or NF monograph, is a component of an FDA-approved drug, or appears on the FDAs 503A bulks list
The preclinical research on BPC-157 as a compound is extensive and growing, with studies in peer-reviewed journals examining its potential for tissue repair support, gut health, musculoskeletal recovery, and inflammatory response modulation in animal models